ArticleBMJ open2018

Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS).

Shinichiro Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.